|
| |
kappaB-Ras
| Symbol: | kappaB-Ras | | Name(s): | kappaB-Ras | | Type: | protein-coding | | Organism: | Drosophila melanogaster | | Synonyms: | BcDNA:RH38596, CG1669, dkappaB-Ras | | Links: |
Pubmed,
Entrez Gene,
Map Viewer.
|
Press Releases on kappaB-Ras:
|
 |
| Transgenomic, Inc. Reports Third Quarter 2009 Results |
5th November, 2009 |
Transgenomic, Inc. |
OMAHA, Neb., Nov. 5 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) today announced financial results for the quarter ended September 30, 2009. The Company&apos
|
| Oncolytics Biotech(R) Inc. Announces 2009 Third Quarter Results |
5th November, 2009 |
Oncolytics Biotech Inc. |
CALGARY, Nov. 5 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced its financial results for the three and
|
| Phase 2 Study of KRX-0401 (Perifosine) in Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma Open for Enrollment at Duke Comprehensive Cancer Center |
8th October, 2009 |
Keryx Biopharmaceuticals, Inc. |
NEW YORK, Oct. 8 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced today the initiation of a Phase 2 clinical study to evaluate KRX-0401 (perifosine) as a
|
| Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement With the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers |
2nd October, 2009 |
|
CALGARY, Canada, October 2 /PRNewswire/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today
announced that it has reached an agreement with the U.S. Food and Drug
|
| Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement with the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers |
2nd October, 2009 |
Oncolytics Biotech Inc. |
--Company to Host Conference Call--
CALGARY, Oct. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that it has
|
kappaB-Ras results (if any) from reagent suppliers | 
|
kappa B-Ras Antibody / kappa B-Ras Antibodies
kappa B-Ras Antibody / kappa B-Ras Antibodies. ... kappa B-Ras specific siRNA, sHRNA Plasmid and shRNA Lentiviral Particles gene silencers are also ...
http://www.scbt.com/table-kappab-ras.html...
|
 |
KappaB ras Antibody NF-κB inhibitor-interacting Ras-like protein
KappaB ras antibody can be used for detection of KappaB ras by Western blot at 2 – 4 μg/ml.,
http://www.prosci-inc.com/shop/catalog1/KappaB-ras-Antibody-...
|
 |
kappa B-Ras Antibody / kappa B-Ras Antibodies
kappa B-Ras specific siRNA, sHRNA Plasmid과 shRNA Lentiviral Particles gene silencers 도 제공합니다. 다음을 포함: siRNAs, shRNA Plasmids, shRNA Lentiviral
...
http://www.scbt.com/ko/table-kappab-ras.html...
|
 |
KappaB ras1 Antibody NF-κB inhibitor-interacting Ras-like protein
KappaB ras1 antibody can be used for detection of KappaB ras1 by Western blot at 0.5 – 1 μg/ml.,
http://www.prosci-inc.com/shop/catalog1/KappaB-ras1-Antibody...
|
 |
kappa B-Ras Antibody / kappa B-Ras Antibodies
kappa B-Ras Anticorpo / kappa B-Ras Anticorpi ... kappa B-Ras specifici siRNA, sHRNA plasmidi e shRNA particelle lentivirali silenziatori del gene sono ...
http://www.scbt.com/it/table-kappab-ras.html...
|
 |
NF-kB p105/p50 Antibody
CD23,CD3/CD28, LPS, Fas, etc. RAS. Rac. SAPK /JNK. Cascade. TRAF-6. IkB. IkB p65 . Rel p50. Proteasome degradation. Active NF-kB. IL-1R ...
http://www.cellsignal.com/pdf/3035.pdf...
|
 |
kappa B-Ras Antibody / kappa B-Ras Antibodies
kappa B-Ras Antibody / kappa B-Ras Antibodies. ... kappa B-Ras 特异siRNA, shRNA 质粒和shRNA 慢病毒颗粒基因沉默子均有产品提供。 ...
http://www.scbt.com/zh/table-kappab-ras.html...
|
 |
Search Bioportfolio and other Life Science Sites for kappaB-Ras,
or search for kappaB-Ras on BioPortfolio's antibody search engine.
This page has been viewed 98 times
Recent Search Terms used to find this page: kappaB-Ras | anti rat PDL-2 antibody | kappaB-Ras antibody | kappaB-Ras antibody | kappaB-Ras 2 antibody | kappaB-Ras 2 antibody | kappaB-Ras 2 antibody | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
